96. Crohn disease Clinical trials / Disease details


Clinical trials : 2,400 Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01957423
(ClinicalTrials.gov)
March 201224/9/2013Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients.Immune Response Regulation and Nutritional Status of Crohn's Disease Patients Under Anti-TNF-alpha and Azathioprine Therapy.Crohn's DiseaseDietary Supplement: Whey protein;Dietary Supplement: Soy proteinUniversity of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São PauloCompletedN/AN/ABoth41N/ABrazil
2NCT00838149
(ClinicalTrials.gov)
November 20055/2/2009Effect of Glutamine on Intestinal Permeability in Crohn's DiseaseEffect of Glutamine Supplementation on the Structure and Function of the Mucosa of Small Intestine in Crohn's Disease: A Randomized Controlled TrialCrohn's DiseaseDietary Supplement: Glutamine;Dietary Supplement: Whey proteinAll India Institute of Medical Sciences, New DelhiNULLCompleted15 Years60 YearsBoth30Phase 1India